SPMs in Cardiology

In this interview, Magnus Back, MD, PhD delves into the role of Specialized Proresolving Mediators (SPMs) in advancing cardiovascular disease treatment. He highlights their potential to enhance current therapies by effectively resolving inflammation. Dr. Back explains how insights from animal models are translating into human treatments, particularly focusing on the effects of SPMs on atherosclerotic lesions and aortic valve stenosis. He also addresses the challenges and opportunities of integrating these findings into practical patient care, underscoring the significant impacts of his research on heart health. Magnus Back, MD, PhD, is a Professor of Cardiology at Karolinska Institute Drop us a comment below on what additional resources you would like to see including topics. Visit us today 👉🏼 https://bit.ly/2WKwqGc Get Social With Metagenics Institute Facebook:   / metagenicsinstitute   X:   / metagenicsinst   Instagram:   / metagenicsinstitute   LinkedIn:   / metagenicsinstitute   #specializedproresolvingmediators #inflammation #aging